These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22079266)

  • 1. Saponins from the Spanish saffron Crocus sativus are efficient adjuvants for protein-based vaccines.
    Castro-Díaz N; Salaun B; Perret R; Sierro S; Romero JF; Fernández JA; Rubio-Moraga A; Romero P
    Vaccine; 2012 Jan; 30(2):388-97. PubMed ID: 22079266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saponin-based adjuvants create a highly effective anti-tumor vaccine when combined with in situ tumor destruction.
    den Brok MH; Nierkens S; Wagenaars JA; Ruers TJ; Schrier CC; Rijke EO; Adema GJ
    Vaccine; 2012 Jan; 30(4):737-44. PubMed ID: 22138178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
    Mo A; Musselli C; Chen H; Pappas J; Leclair K; Liu A; Chicz RM; Truneh A; Monks S; Levey DL; Srivastava PK
    Vaccine; 2011 Nov; 29(47):8530-41. PubMed ID: 21767588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saponin-adjuvanted particulate vaccines for clinical use.
    Skene CD; Sutton P
    Methods; 2006 Sep; 40(1):53-9. PubMed ID: 16997713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.
    Tefit JN; Serra V
    Expert Rev Vaccines; 2011 Aug; 10(8):1207-20. PubMed ID: 21854313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvants for cancer vaccines.
    Dubensky TW; Reed SG
    Semin Immunol; 2010 Jun; 22(3):155-61. PubMed ID: 20488726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant activities of saponins from traditional Chinese medicinal herbs.
    Song X; Hu S
    Vaccine; 2009 Aug; 27(36):4883-90. PubMed ID: 19559122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRX-2 increases the T cell-specific immune response to protein/peptide vaccines.
    Naylor PH; Hernandez KE; Nixon AE; Brandwein HJ; Haas GP; Wang CY; Hadden JW
    Vaccine; 2010 Oct; 28(43):7054-62. PubMed ID: 20708999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine.
    Turmagambetova AS; Alexyuk PG; Bogoyavlenskiy AP; Zaitseva IA; Omirtaeva ES; Alexyuk MS; Sokolova NS; Berezin VE
    Arch Virol; 2017 Dec; 162(12):3817-3826. PubMed ID: 28936557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
    Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8+ T cell response.
    Wong CP; Okada CY; Levy R
    J Immunol; 1999 Feb; 162(4):2251-8. PubMed ID: 9973501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and evaluation of immunological adjuvant activities of saponins from the roots of Pulsatilla chinensis with less adverse reactions.
    Sun Y; Liu J; Yu H; Gong C
    Int Immunopharmacol; 2010 May; 10(5):584-90. PubMed ID: 20159051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccines.
    Liu H; Bungener L; ter Veer W; Coller BA; Wilschut J; Huckriede A
    Vaccine; 2011 Mar; 29(11):2037-43. PubMed ID: 21251903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-A2 and -A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: preclinical study using mice.
    Motomura Y; Ikuta Y; Kuronuma T; Komori H; Ito M; Tsuchihara M; Tsunoda Y; Shirakawa H; Baba H; Nishimura Y; Kinoshita T; Nakatsura T
    Int J Oncol; 2008 May; 32(5):985-90. PubMed ID: 18425324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
    Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains.
    Nico D; Borges RM; Brandão LM; Feijó DF; Gomes DC; Palatnik M; Rodrigues MM; da Silva AJ; Palatnik-de-Sousa CB
    Vaccine; 2012 May; 30(21):3169-79. PubMed ID: 22426042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine.
    Zhou S; Song Y; Nilam A; Luo Y; Huang WC; Long MD; Lovell JF
    J Control Release; 2024 May; 369():687-695. PubMed ID: 38575073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.
    Even-Or O; Samira S; Rochlin E; Balasingam S; Mann AJ; Lambkin-Williams R; Spira J; Goldwaser I; Ellis R; Barenholz Y
    Vaccine; 2010 Sep; 28(39):6527-41. PubMed ID: 20412874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the possible use of saponin adjuvants in COVID-19 vaccine.
    Sharma R; Palanisamy A; Dhama K; Mal G; Singh B; Singh KP
    Hum Vaccin Immunother; 2020 Dec; 16(12):2944-2953. PubMed ID: 33295829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.